Aisthesis Medical will participate in a four-month mentoring program and will compete in the Grand Final
We are proud to announce that Aisthesis Medical has been selected as one of the 20 finalists in the EIT Health InnoStars Awards 2024—Validation Track! This prestigious recognition highlights our dedication to improving patient outcomes through our AI-powered early sepsis prediction tool, VIOSync.
Accelerating Innovation in Healthcare
As part of the EIT Health InnoStars Awards, we will receive tailored mentoring and validation support to further refine our solution and strengthen its market potential.
“This milestone brings us one step closer to transforming acute care and delivering impactful change,” said Dr. Ioannis Gkouzionis, CEO and Co-founder of Aisthesis Medical.
What Does This Mean for Us?
SThe InnoStars Awards focus on nurturing startups with high-growth potential in Central, Eastern, and Southern Europe. As a finalist, Aisthesis Medical will participate in a four-month mentoring program and compete in the Grand Final later this year in Budapest.
About the EIT Health InnoStars Awards
The InnoStars Awards is a flagship program supporting emerging health tech companies by providing funding, mentorship, and validation resources to accelerate the commercialisation of breakthrough solutions.
Follow our journey as we aim for the top and continue striving to make a global impact in healthcare innovation!